This study is looking at two different devices to help treat a type of stroke called an acute ischemic stroke. This happens when a big blood vessel in the brain gets blocked, stopping blood flow. The two devices, Solitaire and Embotrap, help remove the blockage, known as a thrombus. This study will see which device works best on the first try at two hospitals. Researchers will check how long it takes to start treatment, any side effects, and how patients are doing 90 days after the stroke.

Key Points:

• The study will last around 24 months and needs 418 participants.
• Participants will visit Wellstar North Fulton Hospital or Wellstar Kennestone Hospital.
• Participants will be checked 90 days after the stroke either in person or by phone.

To join, you must have had a stroke needing one of these devices and agree to follow study rules. You cannot join if you can't do the 90-day follow-up. This study does not interfere with other clinical trials.